Clinical challenges with calcitonin-negative medullary thyroid carcinoma.

about

Plasma Calcitonin Levels and miRNA323 Expression in Medullary Thyroid Carcinoma Patients with or without RET Mutation Refractory thyroid carcinoma: which systemic treatment to use?

P2860

Q38607292-A4BD350D-578C-4ABA-B16C-195EDA8C2762 Q49335901-CF702B5F-755A-473B-86E9-FBF4621DF169

P2860

Clinical challenges with calcitonin-negative medullary thyroid carcinoma.

Item

http://www.wikidata.org/entity/Q38820275

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Clinical challenges with calcitonin-negative medullary thyroid carcinoma.

@en

type

Item

label

Clinical challenges with calcitonin-negative medullary thyroid carcinoma.

@en

prefLabel

Clinical challenges with calcitonin-negative medullary thyroid carcinoma.

@en

P1476

Clinical challenges with calcitonin-negative medullary thyroid carcinoma

@en

P2093

Alessandro Piovesan

http://www.w3.org/2001/XMLSchema#string

Ezio Ghigo

http://www.w3.org/2001/XMLSchema#string

Francesca Maletta

http://www.w3.org/2001/XMLSchema#string

Francesco Felicetti

http://www.w3.org/2001/XMLSchema#string

Marco Gallo

http://www.w3.org/2001/XMLSchema#string

Maria Teresa Samà

http://www.w3.org/2001/XMLSchema#string

Nadia Bonelli

http://www.w3.org/2001/XMLSchema#string

Nicola Palestini

http://www.w3.org/2001/XMLSchema#string

Ruth Rossetto Giaccherino

http://www.w3.org/2001/XMLSchema#string

P2860

18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels.

Medullary carcinoma of the thyroid gland.

Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma.

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Serum calcitonin negative medullary thyroid carcinoma.

European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium.

Normal perioperative serum calcitonin levels in patients with advanced medullary thyroid carcinoma: case report and review of the literature.

Medullary thyroid carcinoma without marked elevation of calcitonin: a diagnostic and surveillance dilemma.

Medullary thyroid cancer diagnosis: an appraisal.

Serum calcitonin negative medullary thyroid carcinoma: a systematic review of the literature.

P2888

s00432-016-2169-5

P304

2023-2029

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00432-016-2169-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

142

http://www.w3.org/2001/XMLSchema#string

P50

Emanuela Arvat

P577

2016-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27125958

http://www.w3.org/2001/XMLSchema#string

Clinical challenges with calcitonin-negative medullary thyroid carcinoma.

about

P2860

P2860

Clinical challenges with calcitonin-negative medullary thyroid carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698